Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a new 150 mg dosing arm for Part 2, long-extension/open-label options, IPD sharing documents, and new locations; several Part 1 dose cohorts and placebo arms were removed, reflecting a revised trial structure.SummaryDifference5%

- Check11 days agoChange DetectedFooter revision indicator has been updated from v3.6.5 to v3.6.6, reflecting a software update to the site.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the page. No changes to the study details or other visible content are indicated.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the study details page. This suggests a small metadata or formatting adjustment rather than substantive changes to the study content.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a minor update to the page’s revision history for the study record.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a new build/version of the page.SummaryDifference0.0%

Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.